TRACON Pharmaceuticals, Inc. (TCON)

TRACON Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	12.15	12.05	0	0.35	0	0
Cost of Revenue	0.01	0.01	0.02	0.01	0.01	0.02
Gross Profit	12.13	12.03	-0.02	0.33	-0.01	-0.02
Selling, General & Admin	5.76	6.67	14.01	17.55	8.03	7.77
Research & Development	9.18	12.26	13.89	11.15	8.2	14.53
Other Operating Expenses	7.48	12.99	-1.24	-0.32	-0.01	-0.38
Operating Expenses	19.31	18.93	27.89	28.69	16.22	22.3
Operating Income	-5.17	-6.9	-27.89	-28.35	-16.22	-22.3
Interest Income	-1.19	0	0.99	0.32	0.55	0.39
Interest Expense	-6.14	7.3	0.99	0.32	0.55	0.39
Other Expense / Income	0.41	-10.61	1.24	0.32	0.55	0.38
Pretax Income	1.75	-3.59	-29.14	-28.67	-16.78	-22.67
Income Tax	-2.38	0	0.18	0.06	0.55	-0.02
Net Income	1.75	-3.59	-29.31	-28.73	-17.33	-22.66
Shares Outstanding (Basic)	2	33	21	17	9	3
Shares Outstanding (Diluted)	2	33	21	17	9	3
Shares Change	-89.92%	56.53%	21.25%	92.03%	196.09%	12.61%
EPS (Basic)	-1.23	-0.11	-1.40	-1.67	-1.93	-7.47
EPS (Diluted)	-1.23	-0.11	-1.40	-1.67	-1.93	-7.47
Free Cash Flow	6.14	3.68	-26.26	-22.62	-17.05	-23.65
Free Cash Flow Per Share	2.57	0.11	-1.26	-1.31	-1.90	-7.79
Gross Margin	99.88%	99.88%	-	95.95%	-	-
Operating Margin	-42.59%	-57.27%	-	-8192.77%	-	-
Profit Margin	14.39%	-29.79%	-	-8302.31%	-	-
Free Cash Flow Margin	50.52%	30.52%	-	-6537.28%	-	-
Effective Tax Rate	-136.10%	-	-	-	-	-
EBITDA	-5.17	-6.88	-27.89	-28.35	-16.23	-22.3
EBITDA Margin	-42.53%	-57.15%	-	-8192.77%	-	-
Depreciation & Amortization	0.02	0.01	0.07	-0.06	-0.01	0.02
EBIT	-5.19	-6.9	-27.96	-28.29	-16.22	-22.31
EBIT Margin	-42.72%	-57.27%	-	-8175.72%	-	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.